z-logo
open-access-imgOpen Access
Subcutaneous implants for long-acting drug therapy in laboratory animals may generate unintended drug reservoirs
Author(s) -
Michael Guarnieri,
Betty Tyler,
Louis J. DeTolla,
Ming Zhao,
Barry J. Kobrin
Publication year - 2014
Publication title -
journal of pharmacy and bioallied sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.268
H-Index - 36
eISSN - 0976-4879
pISSN - 0975-7406
DOI - 10.4103/0975-7406.124315
Subject(s) - drug , implant , medicine , bioavailability , pharmacology , drug delivery , pharmacokinetics , surgery , chemistry , organic chemistry
Long-acting therapy in laboratory animals offers advantages over the current practice of 2-3 daily drug injections. Yet little is known about the disintegration of biodegradable drug implants in rodents.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here